Current Edition


Merck brings former executive back to lead ex-US pharmaceuticals business

Dive Brief: Merck has tapped a former executive, Joseph Romanelli, to run the company’s pharmaceutical business in markets outside the U.S. after restructuring its human …

Continue Reading →

Why the FDA is making a test case of a cancer drug from China

At a quick glance, the Food and Drug Administration’s decision to ask its advisers for help in vetting yet another cancer immunotherapy may seem odd. …

Continue Reading →

Merck’s Keytruda gets approval in China for advanced melanoma

Melanoma is one of the fastest growing malignant cancers in China, increasing at an annual rate of 3-5 percent, which makes it one of the …

Continue Reading →

Innovent receives IND approval to initiate Clinical Trials in China

Innovent’s IBI101, is the first OX40-targeted molecule to receive IND approval in China Innovent Biologics, a world-class China-based biopharmaceutical company that develops and intends to …

Continue Reading →

Nuance enters $58 M deal for non-opioid pain treatment in China

EXPAREL is a non-opioid option for achieving long-lasting pain control after surgery via infiltration into the surgical site or administration as an interscalene brachial plexus …

Continue Reading →

Suven Life Sciences gets patents in China and US

These patents add to the similar protections won in countries such as India, Korea, Singapore, Canada, Japan and Australia in the past. Suven Life Sciences …

Continue Reading →